SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $59.2 million in its fourth quarter.
The San Diego-based company said it had a loss of 9 cents per share. Losses, adjusted for non-recurring gains, were 15 cents per share.
The immunotherapy company posted revenue of $7.6 million in the period.
For the year, the company reported a loss of $413.6 million, or 62 cents per share. Revenue was reported as $14.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
